Apyx Medical CFO Matthew C. Hill Granted 132,066 Stock Options at $4.65 Exercise Price

Matthew C. Hill, Chief Financial Officer of Apyx Medical Corp, was granted 132,066 stock options on June 11, 2026, with an exercise price of $4.65 per share. The options have a 10-year term expiring on June 11, 2036. According to the filing, the options will vest ratably over a 36-month period and become fully vested and exercisable on the third anniversary of the grant date. The transaction was reported on Form 4, indicating a non-derivative securities acquisition by an officer of the company. This represents a significant equity-based compensation award to the CFO, aligning his interests with shareholders through long-term incentives tied to the company's stock performance.